Europe PMC How Europe PMC can help you find associations between genes and diseases In this day and age of information deluge, how do you stay up-to-date with the latest advances in the field of drug discovery? The chances are you read publications, preprints, patents, or other
release notes The latest release of the Open Targets Platform is out! We have just released the latest version of the Open Targets Platform, release 18.04. These are some of the highlights. Our favourite stats Targets Diseases Evidence Associations 21,016 9,700 6,
Open Targets Touring with Takeda You may have seen the news on Takeda joining Open Targets from December last year. Takeda (native name 武田薬品工業株式会社) was founded in Doshomachi, Osaka, Japan in 1781. It started as a small shop
Open Targets Open Targets Platform: we have a new release We have just released the latest version of the Open Targets Platform, release 18.02. These are some of the highlights. Our favourite stats targets diseases evidence associations 20,974 9,728 5,
release notes Open Targets Platform: our December release is out! We have just released the latest version of the Open Targets Platform, release 17.12. Why not start exploring it now before you break up for the festive season? Data statistics targets diseases
release notes Open Targets Platform: our latest release is out! We have just released the latest Open Targets Platform, release 17.09. Let's crunch some of the numbers before moving on to our highlights: targets diseases evidence associations 19,803 9,341 6,
Open Targets Platform What is new in the latest release of the Open Targets Platform? The latest version of our Open Targets Platform is out. We have more diseases, more evidence, more associations, more data sources, but fewer targets. If you wonder what and why, keep reading. Let's
Open Targets Translation, Translation, Translation Over the last 14 days, we have had two scientific meetings taking place right here on the Wellcome Genome Campus, the Translational Bioinformatics conference and the Translational Target Validation symposium. What did they
targetvalidation.org Breaking news: extra data in our Open Targets Platform! We have released our latest version of the Open Targets Platform with new and updated data. This is our 17.04 data release. Wonder what are the highlights? In a nutshell: more targets,
Open Targets Platform How to access Open Targets with a list of targets and no programmatic skills You may have read our post on how to Get an association table for your list of genes using the REST API. And thought: "I wish I could search for my list
targetvalidation.org Our latest release is out: it's all about data The latest release of our Open Targets Platform is out. Are you looking for more targets, more diseases, more evidence, more associations, or perhaps all of the above? If you said yes, the
Open Targets Open Targets - First Impressions I recently joined the Open Targets Consortium as Operations Director. This moved me from almost the very end of the R&D pipeline where I had been working on processes for small
targetvalidation.org Did you see the latest version of Open Targets Platform? That's right. The Open Targets Platform v1.2 is out! In this release, we have new web displays and plenty of extra data to assist you in drug discovery and validation: 30,591
Open Targets Outreach in Open Targets: supercharge your target identification skills What is it? Outreach, you may have heard the word before. But what is it, really? According to the Cambridge Dictionary, outreach is an effort to bring services or information to people where
